Here are 15 key notes:
1. During the second quarter, net sales reached $104.1 million, up 3.1 percent from the same period of 2015.
2. The company’s BioStim segment generated nearly $44.758 million in net sales due to rising order counts from a wider customer base and cash process improvements.
3. Orthofix’s extremity fixation segment had net sales reaching $26.917 million, up 4.8 percent from the same period last year.
4. The spine fixation segment’s net sales were down 5.9 percent, hitting $18.244 million as the company lost various U.S. surgeon customers, experienced poor timing in international cash collections and was excluded from a large national hospital account.
5. The company’s gross profit reached $81.6 million, up from $2.5 million in the same period last year.
6. Orthofix’s gross margin rallied to 78.4 percent from 78.3 percent during the second quarter of 2015.
7. The company’s net margin was $84.2 million, up from $74.1 million in the second quarter the year prior.
8. Orthofix’s operating loss totaled $2.6 million, less than $4.9 million in the same quarter last year.
9. Net loss from continuing operations was $6.3 million, or $0.35 per share, for the second quarter.
10. Adjusted net income from continuing operations was $7.5 million, up from $6.3 million the same period last year.
11. The company’s EBITDA was $2.6 million, down from $11 million last year in the second quarter.
12. Orthofix had cash and cash equivalents of $40.5 million as of June 30, 2016.
13. For 2016, Orthofix expects net sales between $412 million and $416 million, and adjusted EBITDA to fall between $69 million and $72 million.
14. Orthofix expects net income from continuing operations between $9 million and $13 million for 2016.
15. For 2016, Orthofix expects earnings per share from continuing operations between $0.48 and $0.68.
More articles on devices:
Mazor Q2 revenue hits $8.3M after Medtronic investment: 10 key notes
Smith & Nephew revenue hits $1.1B, up 2% in Q2: 5 things to know
NuVasive appoints two new board members: 3 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
